<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04390000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P55212</UniProt_ID>
  <Seq_Length>293</Seq_Length>
  <Molecule_Weight>33310</Molecule_Weight>
  <KEGG_ID>hsa:839</KEGG_ID>
  <Orthology_ID>K04396</Orthology_ID>
  <EBI_ID>EBI-718729</EBI_ID>
  <Function_Summary>Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves poly(ADP-ribose) polymerase in vitro, as well as lamins. Overexpression promotes programmed cell death.</Function_Summary>
  <Catalytic_Mechanism>Strict requirement for Asp at position P1 and has a preferred cleavage sequence of Val-Glu-His-Asp-|-.</Catalytic_Mechanism>
  <Pfam_ID>PF00656:Peptidase_C14</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>8</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Caspase-6 subunit p11</Alias>
      <Alias>CASP-6</Alias>
      <Alias>Apoptotic protease Mch-2</Alias>
      <Alias>Caspase-6 subunit p18</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008234</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004197</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>182</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>35</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>109</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis</Keyword>
      <Ontology_ID>GO:0006917</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The breakdown of structures such as organelles, proteins, or other macromolecular structures during apoptosis.</Detail>
      <Keyword>Cellular component disassembly involved in apoptosis</Keyword>
      <Ontology_ID>GO:0006921</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>257</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MSSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSN</Protein_Seq>
    <DNA_Seq>CCGAGGGCGGGGCCGGGCCCGGGAGCCTGTGGCTTCAGGAAGAGGAGGGCAAGGTGTCTGGCTGCGCGTTTGGCTGCAATGAGCTCGGCCTCGGGGCTCCGCAGGGGGCACCCGGCAGGTGGGGAAGAAAACATGACAGAAACAGATGCCTTCTATAAAAGAGAAATGTTTGATCCGGCAGAAAAGTACAAAATGGACCACAGGAGGAGAGGAATTGCTTTAATCTTCAATCATGAGAGGTTCTTTTGGCACTTAACACTGCCAGAAAGGCGGGGCACCTGCGCAGATAGAGACAATCTTACCCGCAGGTTTTCAGATCTAGGATTTGAAGTGAAATGCTTTAATGATCTTAAAGCAGAAGAACTACTGCTCAAAATTCATGAGGTGTCAACTGTTAGCCACGCAGATGCCGATTGCTTTGTGTGTGTCTTCCTGAGCCATGGCGAAGGCAATCACATTTATGCATATGATGCTAAAATCGAAATTCAGACATTAACTGGCTTGTTCAAAGGAGACAAGTGTCACAGCCTGGTTGGAAAACCCAAGATATTTATCATTCAGGCATGTCGGGGAAACCAGCACGATGTGCCAGTCATTCCTTTGGATGTAGTAGATAATCAGACAGAGAAGTTGGACACCAACATAACTGAGGTGGATGCAGCCTCCGTTTACACGCTGCCTGCTGGAGCTGACTTCCTCATGTGTTACTCTGTTGCAGAAGGATATTATTCTCACCGGGAAACTGTGAACGGCTCATGGTACATTCAAGATTTGTGTGAGATGTTGGGAAAATATGGCTCCTCCTTAGAGTTCACAGAACTCCTCACACTGGTGAACAGGAAAGTTTCTCAGCGCCGAGTGGACTTTTGCAAAGACCCAAGTGCAATTGGAAAGAAGCAGGTTCCCTGTTTTGCCTCAATGCTAACTAAAAAGCTGCATTTCTTTCCAAAATCTAATTAATTAATAGAGGCTATCTAATTTTACACTCTGTATTGAAAATGGCTTTCTCAGCCAGGCGTGGTTACTCACACCTGTAATCCCAGCACTTTGGGAGTCCAAGGTGGGCGGATCACCTGAGGTCGGGAGTTCGAGACCAGCCTGACCAACATGGAGAAGCCCCGTCTCTACTAAAAATGCAAAAAAAAATTTAGCTAGGCATGGCGGCGCATGCCTGCAATCCCAGCTACTTGGAAGGCTGAGGCAGGAGAATCACTTGAACCCAGGAGGTGGAGGCTGCGGTGAGCCGAGATTGCGCCATTGCACTCCAGCCTGGGCAACGAGTGAAACTCCGTCTCAAAAAAAAGAAAATGTCTTTCTCTTCCTTTTATATAAATATCGTTAGGGTGAAGCATTATGGTCTAATGATTCAAATGTTTTAAAGTTTAATGCCTAGCAGAGAACTGCCTTAAAAAAAAAAAAAAAAAGTTCATGTTGGCCATGGTGAAAGGGTTTGATATGGAGAAACAAAATCCTCAGGAAATTAGATAAATAAAAATTTATAAGCATTTGTATTATTTTTTAATAAACTGCAGGGTTACACAAAAATCTAGCTGATTTAACTTGTATTTTGTCACTTTTTTATAAAAGTTTATTGTTTGATGTTTTTAAAGGTTTTTGAAATCCAGGAATTAAATCATCCCTTAATAAAATATTCGAAATTC</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleoplasm</CellLocal>
      <Ontology_ID>GO:0005654</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CASP6</Gene_Name>
    <Gene_Alias>MCH2</Gene_Alias>
    <Gene_ID>839</Gene_ID>
    <Genbank_ACCN>NM_001226</Genbank_ACCN>
    <Protein_ACCN>NP_001217</Protein_ACCN>
    <HGNC_ID>1507</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/839</Gene_URL>
    <UCSC_ID>uc003hzo.1</UCSC_ID>
    <EMBL_ID>ENSG00000138794</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q01826</Uniprot_ID>
      <Gene_Name>SATB1</Gene_Name>
      <EBI_ID>EBI-743747</EBI_ID>
      <PPI_EBI_URL>EBI-718729,EBI-743747</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=CASP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thoracic Cancer</Disease_Name>
      <Disease_Detail>Thoracic Cancer</Disease_Detail>
      <Disease_DB>THR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thoracic_cancer?search=CASP6#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Huntington's Disease</Disease_Name>
      <Disease_Detail>Huntington's Disease</Disease_Detail>
      <Disease_DB>HNT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/huntingtons_disease?search=CASP6#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6</PDB_Title>
      <PDB_ID>4N6G</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4N6G</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390002</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Allosteric peptides that bind to a caspase zymogen and mediate caspase tetramerization</PDB_Title>
      <PDB_ID>4EJF</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4EJF</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390003</ASD_Ligand>
      <PubMed_Title>Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization.</PubMed_Title>
      <Author>Stanger, K., et al.</Author>
      <Journal>Nat.Chem.Biol.(2012)8:655-660</Journal>
      <PubMed_ID>22683611</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6</PDB_Title>
      <PDB_ID>4N7J</PDB_ID>
      <Resolution>1.67</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4N7J</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390002</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human ligand-free mature caspase-6 with intersubunit linker attached</PDB_Title>
      <PDB_ID>3NKF</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NKF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Substrate-Induced Conformational Changes Occur in All Cleaved Forms of Caspase-6.</PubMed_Title>
      <Author>Vaidya, S., et al.</Author>
      <Journal>J.Mol.Biol.(2011)406:75-91</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21111746?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6: Cpd1</PDB_Title>
      <PDB_ID>4N5D</PDB_ID>
      <Resolution>2.06</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4N5D</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390001</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6</PDB_Title>
      <PDB_ID>2WDP</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WDP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Crystal Structure of Caspase-6, a Selective Effector of Axonal Degeneration.</PubMed_Title>
      <Author>Baumgartner, R., et al.</Author>
      <Journal>Biochem.J.(2009)423:429-439</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19694615?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of active caspase-6 in complex with Ac-VEID-CHO inhibitor</PDB_Title>
      <PDB_ID>3P4U</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3P4U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of active and inhibitor-bound human Casp6</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6</PDB_Title>
      <PDB_ID>4NBK</PDB_ID>
      <Resolution>1.94</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4NBK</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390010</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of caspase-6 inactivation mutation</PDB_Title>
      <PDB_ID>3V6L</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V6L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Inhibitory mechanism of caspase-6 phosphorylation revealed by crystal structures, molecular dynamics (MD) simulations and biochemical assays</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Inhibition of caspase-6 activity by single mutation outside the active site</PDB_Title>
      <PDB_ID>3V6M</PDB_ID>
      <Resolution>2.69</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V6M</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Inhibitory mechanism of caspase-6 phosphorylation revealed by crystal structures, molecular dynamics (MD) simulations and biochemical assays</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Zinc-mediated allosteric inhibiton of caspase-6</PDB_Title>
      <PDB_ID>4FXO</PDB_ID>
      <Resolution>2.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FXO</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01310003</ASD_Ligand>
      <PubMed_Title>Zinc-mediated Allosteric Inhibition of Caspase-6.</PubMed_Title>
      <Author>Velazquez-Delgado, E.M., et al.</Author>
      <Journal>J.Biol.Chem.(2012)287:36000-36011</Journal>
      <PubMed_ID>22891250</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of apo-caspase-6 at physiological pH</PDB_Title>
      <PDB_ID>3P45</PDB_ID>
      <Resolution>2.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3P45</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of active and inhibitor-bound human Casp6</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human ligand-free mature caspase-6</PDB_Title>
      <PDB_ID>3K7E</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3K7E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-function analysis of caspase-6</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Caspase-6 zymogen</PDB_Title>
      <PDB_ID>3NR2</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NR2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation</PubMed_Title>
      <Author>Wang, X.-J., et al.</Author>
      <Journal>Embo Rep.(2010)11:841-847</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20890311?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6</PDB_Title>
      <PDB_ID>4NBL</PDB_ID>
      <Resolution>1.76</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4NBL</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390011</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of active caspase-6 bound with Ac-VEID-CHO</PDB_Title>
      <PDB_ID>3OD5</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OD5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation</PubMed_Title>
      <Author>Wang, X.-J., et al.</Author>
      <Journal>Embo Rep.(2010)11:841-847</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20890311?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Caspase-6 in complex with Z-VAD-FMK inhibitor</PDB_Title>
      <PDB_ID>3QNW</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3QNW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of human caspase-6 in complex with Z-VAD-FMK: New peptide binding mode observed for the non-canonical caspase conformation.</PubMed_Title>
      <Author>Muller, I., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2011)21:5244-5247</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21820899?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6</PDB_Title>
      <PDB_ID>4N7M</PDB_ID>
      <Resolution>2.12</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4N7M</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04390002</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Tailoring Small Molecules for an Allosteric Site on Procaspase-6</PDB_Title>
      <PDB_ID>4NBN</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4NBN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00530008</ASD_Ligand>
      <PubMed_Title>Tailoring small molecules for an allosteric site on procaspase-6.</PubMed_Title>
      <Author>Murray, J., et al.</Author>
      <Journal>Chemmedchem(2014)9:73-77</Journal>
      <PubMed_ID>24259468</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04210</Pathway_ID>
      <Pathway_Title>Apoptosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
  </Network_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.22.59</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/22/59.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00070007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00530008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01240008</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01310003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04390001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04390002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04390003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04390010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04390011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>